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Background: Venous ulcers are a major health problem because of their high prevalence and associated high cost of care.
Compression therapy is the most widely used treatment for this condition. The vast majority of published articles on
compression therapy present the results in the treatment of venous ulcers usually up to 15 to 20 cm2. However, there are
no published data in Englishmedical literature on the efficacy of compression therapy in the treatment of extensive venous
ulcers (ulcers>20 cm2 of more than 6 months’ duration) with regard to healing rate, time to healing, and recurrence rate
at 12 months after healing.
Methods: A total of 138 patients with extensive venous ulceration (ulceration surface, 20-210 cm2; duration, 7 months to
28 years) were randomized into 2 groups: (1) a treatment group (72 patients who were treated by using a multilayer
bandaging system with the Tubulcus (a heelless open-toed elastic compression device knitted in tubular form) and elastic
bandages and (2) a control group (66 patients treated with a multilayer bandaging system with elastic bandages only).
The patients were treated on an ambulatory basis; the primary end point of the study was complete ulcer healing at 500
days. The secondary end point was to assess the ulcer recurrence rate during continuation of below-knee compression of
different degrees of compression. In the treatment group, patients were instructed to continue to wear the Tubulcus (35
mmHg), and patients in the control group were instructed to wear compression stockings with compression of 20 to 25
mm Hg. The exclusion criteria from the study were heart insufficiency with an ejection fraction <35, an ankle-brachial
pressure index less than 0.8, and pregnancy.
Results: The cumulative healing rate was 93% in the treatment group and was 51% in the control group (P < .001). The
median healing time in the treatment group was 133 days (range, 28 to 464 days), and in the control group it was 211
days (range, 61 to 438 days). The recurrence rate at 12 months in the treatment group was 24% (16/67) and was 53%
(18/34) in the control group (P< .05). After additional compression treatment with the same treatment protocol, all 16
recurrent ulcers in the treatment group healed. In the control group, the healing rate of recurrent ulcers was 89%
(16/18).
Conclusions: This study suggests that for extensive venous ulceration, multilayer compression therapy with the Tubulcus
provides an extremely high healing rate. Compression of more than 30 mm Hg results in decreased ulcer recurrence.
However, recurrence cannot be completely avoided. (J Vasc Surg 2007;46:750-5.)Venous ulcers are a major health problem because of
their high prevalence and associated high cost of care.
Compression therapy is the most widely used treatment for
this condition, and it has been used in different forms for
more than 350 years.1 The mechanism of action of com-
pression therapy in the treatment of venous leg ulcers is not
completely understood. According to numerous studies, it
has been suggested that the application of external pressure
to the calf muscle increases the interstitial pressure, thus
resulting in improved venous return and reduction in ve-
nous hypertension.2-4 The vast majority of published stud-
ies on the treatment of venous leg ulcers using compression
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750therapy are related to venous ulcers smaller than 20 cm2,
and the primary end point is complete ulcer healing at 12 or
24 weeks. However, there are no published data in the
English medical literature on the efficacy of the compres-
sion therapy in the treatment of extensive venous ulcers
(ulcers 20 cm2 of more than 6 months’ duration) with
regard to healing rate, time to healing, and recurrence rate
at 12 months after healing. Several risk factors have been
identified to be correlated with the failure of venous leg
ulcers to heal with compression therapy: longer ulcer dura-
tion, large surface area, fibrinous deposition present on
more than 50% of the wound surface, and an ankle-brachial
pressure index of less than 0.8.5 The purpose of this study
was to compare the efficacy and safety of two different
multilayer bandaging systems in the treatment of extensive
venous ulcers.
METHODS
With a power of 80% (  20%) and a significance level
of   5%, assuming a healing rate of 80%, with the
recruitment period of 1 year (considering the difference
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in-patient standard deviation), 120 patients were needed
for the study. Because the patient population included in
this study could differ to some extent, and allowing for a
dropout rate of 10% to 20%, a sample size of 150 patients
was calculated to be required for the study.
Patients aged at least 18 years with leg ulceration of
venous etiology were screened for inclusion in the trial.
Before randomization, all patients underwent color duplex
scan examination and ankle-brachial pressure index mea-
surements. Examinations were performed by using a Sie-
mens Sonoline Sienna (Erlangen, Germany) ultrasonogra-
phy device with a 7-MHz probe. Venous compressibility
and flow characteristics were the key elements to exclude
thrombosis. The direction of flow was assessed in a 20° to
30° reverse Trendelenburg position during the Valsalva
maneuver. A cuff inflation-deflation method with rapid cuff
deflation in the standing position was performed to induce
reflux. The presence of reflux was determined by retrograde
flow of longer than 0.5 seconds.
Patients with arterial disease (ankle-brachial pressure
index 0.8) and causes of ulceration other than venous
disease were excluded from the study. The study also
excluded patients with heart insufficiency (ejection fraction
35), pregnancy, cancer disease, and diabetes. Only pa-
tients with extensive venous ulcers (surface 20 cm2 with
duration longer than 6months) were included in the study.
Wound size was determined by measurement (maximal
length and width) and by a computerized process that
consisted of mapping the two-dimensional digital image
onto a polygonal mesh.
One hundred seventy-eight patients were considered for
the study, and 150 were randomized. Randomization was
computer generated, and patients were randomized into two
groups. The first group (treatment group) consisted of 75
patients treatedwith amultilayer bandaging system consisting
of a tubular compression device (Tubulcus; Laboratoires
Innothera, Arcueil, France) and a medium-stretch com-
pression bandage (100% stretch), 15 cm wide and 5 m long
(Niva, Novi Sad, Serbia). The second group (control
group) consisted of 75 patients treated with two elastic
medium-stretch compression bandages (15 cm  5 m,
100% stretch; Niva). Wound swabbing was performed to
identify the microbiologic status of the ulcer. If the ulcer
did not heal by 250 days, a biopsy was performed.
The study was approved by the relevant authorities, and
written consent was obtained from all patients included in
the study. All patients in both groups were treated by the
same treatment team.
After ulcers have healed, two patients in the treatment
group didn’t show ulcers during the follow-up period, and
one patient had a stroke. In the control group, one patient
died in a car accident, and eight patients withdrew their
written consent for inclusion into the study, demanding to
change treatment groups. A total of 138 patients (72
women and 66 men; mean age, 56 years) with extensive
venous ulceration (ulceration surface, 20-210 cm2; dura-
tion, 7 months to 28 years) completed the study (72patients in the treatment group and 66 patients in the
control group). The patients were treated on ambulatory
basis, and the primary end point of the study was complete
ulcer healing at 500 days. The secondary end point was to
assess the ulcer recurrence rate during the continuation of
below-knee compression of different degrees of compres-
sion. In the treatment group, patients were instructed to
continue to wear the Tubulcus (35 mm Hg), and patients
in the control group were instructed to wear compression
stockings with compression of 20 to 25 mm Hg (Rudo,
Nis, Serbia). Patients were reviewed every 2 months during
the 1-year follow-up period and were advised to continue
wearing stockings long-term, although compliance was not
formally assessed. Stockings were replaced every 6 months.
All patients were advised to return to the clinic if ulceration
recurred.
Treatment regimen. The standard regimen was to
debride the wound. This was normally simple mechanical
debridement with sterile gauze to remove slough and other
dead tissue. According to the extent of wound exudation,
dressings were changed every 1 to 7 days. Extensive wound
exudation was treated with crystal acidum boricum (after
debridement, acidum boricum was applied over the wound
in a thin layer), and in patients with no exudation, dry
dressings were performed. No antibiotics were used, and
patients in both groups received only aspirin (100 mg).
After wound debridement and dressing, bandaging systems
were applied. The bandaging systems were applied as fol-
lows.
The first and second layers in both groups were the
same: cotton gauze without tension (50% overlap) and
cotton crepe bandage. The third layer in the treatment
group consisted of a ready-made knee-length tubular com-
pression device (Tubulcus) that exerts graduated pressure,
with the highest compression (35-40 mmHg) at the ankle,
diminishing up the calf. Device size was determined for
each patient according to the circumferences of the leg
measured at the ankle and the largest part of the calf (five
sizes—S,M, L, XL, and XXL—were available). The circum-
ference of the limb was measured every 4 weeks during the
treatment, and according to these measurements a Tubul-
cus was applied. If the measurements of the limb stayed at
the initial size, the Tubulcus was changed after 6 months.
The first step to put on the compression device is the
placement of the positioner on the lower leg (over the local
dressing). Then the device is slipped over the positioner to
the desired position. The positioner is then removed by
pulling it down by the handle toward the opening in the
foot section. As the positioner is gliding on itself and not on
the local dressing, there is no danger that the dressing
moves down when the device is pulled off.6
The third layer in the control group was elastic medium-
stretch bandage (100% stretch), 15 cm wide and 5 m long, in
a spiral with a 50%overlap, and the fourth layer in both groups
was the same:medium-stretch elastic bandage (100% stretch),
15 cm wide and 5 m long, in a spiral with a 50% overlap. The
elastic bandages were applied with the patient in the recum-
bent position and the foot in dorsal flexion. Elastic bandages
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advised to walk 30 minutes after bandaging.
Interface pressure was measured under the Trickovic
sensor system (Nis, Serbia) with piezo resistance sensors at
one site on the lower leg (8 cm above the medial malleolus)
and with the patient in the supine position. The pressure
was measured on three occasions, and the mean value for
each patient was taken for statistical analysis.
End points and statistical analyses. The primary end
point of the study was complete ulcer healing at 500 days.
In cases in which the original ulcer closed but a new area
developed on the same limbwhile the original ulcer was still
present, the limb was considered to be open until this new
area of ulceration had also closed. The definition of ulcer
closure was the point at which complete epithelialization of
the reference limb occurred. Patients with ulcer closure
were provided in the control group with class II (20-25mm
Hg) compression hosiery (Rudo), whereas in the treatment
group patients continued to wear the Tubulcus. Patients
were followed up until 52 weeks to determine the recur-
rence rate.
Statistical methods. Log-rank life-table analysis was
used to compare healing rates in the two treatment groups.
Cox regression analysis with the backward method was
performed to determine whether covariates (age, sex, ul-
ceration surface, time since ulcer onset, previous opera-
tions, history of deep vein thrombosis, body mass index,
and wound swabbing results) significantly influenced the
time to healing. The Fisher exact test was used to compare
categorical parameters between groups, and the Mann-
WhitneyU test was used to compare values of noncategori-
cal parameters. Analyses were performed with SPSS 10.0
(SPSS Inc, Chicago, Ill).
RESULTS
Demographics and ulcer characteristics are listed in
Table I. Both groups were well matched for age, sex,
medical history, and ulcer characteristics. The mean patient
age for the entire study population was 56 years (range, 33
to 81 years). Fifty-one percent of the patients were female,
and 54% of the ulcers affected the left leg.
The median number of previous episodes of ulceration
was 5 (range, 1 to 11). In the treatment group, 78% of
Table I. Characteristics of the treatment and control
groups
Variable
Treatment
group
(n  75)
Control
group
(n  7)
P
value
Male:female ratio 39:36 34:41 .41
Age (y) 55 (33-80) 57 (34-81) .37
Previous episodes of
ulceration (No)
5 (2-10) 5 (1-11) .33
Size of the ulcer (cm2) 72 (24-210) 64 (20-195) .61
Duration of the ulcer (y) 7 (0.6-28) 6 (0.6-21) .52
Data are median (range) unless otherwise noted.ulcers were medial, 15% were lateral, 5% were circumferen-tial, and 2% were a combination. In the control group, 81%
of ulcers were medial, 11% were lateral, 4% were circumfer-
ential, and 4% were a combination. Twenty-five patients
(35%) in the treatment group and 20 patients (30%) in the
control group had previous deep vein thrombosis. No
significant difference was observed between the treatment
and control groups according to the CEAP classification
(Table II).
Pain, edema, pigmentation, and lipodermatosclerosis
were present in all 138 patients (100%). In the treatment
group, 14 patients (19%) had previously had stripping of
great saphenous vein, and 5 patients (7%) had had a super-
ficial endoscopic perforator vein surgery procedure. Twelve
patients (18%) in the control group had previously had
stripping of a great saphenous vein, and five patients (8%)
had had a superficial endoscopic perforator vein surgery
procedure. During the observation period, neither surgery
nor sclerotherapy was performed in the patients included in
the study.
Interface pressure in the treatment group was 50 mm
Hg (range, 46 to 56 mm Hg) and was 44 mm Hg in the
control group (range, 37 to 49 mm Hg). The bandaging
systems were worn day and night. Although compliance
was not formally assessed, there were no withdrawals from
the study because of noncompliance. It is interesting that
none of the patients included in this study had previously
received compression therapy.
The median healing time in the treatment group was
133 days (range, 28 to 464 days), and in the control group
it was 211 days (range, 61 to 438 days) (Graph 1). The
ulcer with the largest surface in the treatment group and
entire study, covering almost the entire circumference of
the leg (210 cm2), healed in 280 days (Figs 1 and 2).
The recurrence rate during the 1-year follow-up period
was 24% (16/67) in the treatment group and was 53%
(18/34) in the control group (P .05). Among 34 recur-
rent ulcers in both groups, 14 (41%) occurred not at the
original site of the ulcer, but below the medial malleolus.
Table II. Distribution of patients in the examined
groups according to CEAP classification
Variable
Treatment
group
Control
group
P
value
Clinical
C6 72 (100%) 66 (100%)
Etiologic
Primary 42 (58%) 40 (61%)
Secondary* 30 (42%) 26 (39%) .78
Anatomic
Deep 16 (22%) 19 (29%) .49
Perforator 36 (50%) 31 (47%) .72
Superficial  perforator 16 (22%) 13 (20%) .72
Superficial  deep 4 (6%) 3 (5%) .99
Pathophysiologic
Reflux 61 (85%) 57 (86%)
Reflux  obstruction 11 (15%) 9 (14%) .78
*Secondary etiology was based on ultrasound findings.These recurrent ulcers were typically 2 1 cm in diameter,
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sion treatment using the same treatment protocol, all 16
recurrent ulcers in the treatment group healed. In the
control group, the healing rate for recurrent ulcers was 88%
(16/18).
Lateral side ulcers seem to be more difficult to heal, but
Graph 1. Cumulative healing rate of venous leg ulcers in the
treatment and control groups.
Fig 1. The ulcer with the largest surface in the entire study (210
cm2) at the beginning of the treatment.the sample size was too small to prove a statistically signif-icant difference. There were no deaths or major complica-
tions in either group. Adverse events in the treatment
group were skin excoriations on the front of the ankle and
1 inch below the knee (12/72; 17%). In 47% of patients
(34/72), the upper end of the tubular device was hardly
controlled, showing a tendency to slip below the knee and
cause additional pressure and pain. In the control group,
pain was present more often compared with the treatment
group at the beginning of the treatment (19/66 [29%] vs
8/72 [11%]). The different variables analyzed for associa-
tion with the outcome of compression therapy are listed in
Table III. None was statistically significant.
DISCUSSION
The goals of compression therapy in the treatment of
Fig 2. Ulcer healed at the 280-day treatment mark.
Table III. Covariates entered into the Cox regression
model with the backward method
Variables not in the equation OR 95% CI
P
value
Age 1.205 0.793-1.832 .38
Sex 0.997 0.975-1.019 .78
Ulceration surface 0.999 0.995-1.004 .82
Time since ulcer onset 1.001 0.998-1.003 .61
Previous operations 1.197 0.799-1.795 .38
History of deep vein
thrombosis
0.883 0.554-1.409 .60
Body mass index 1.170 0.543-1.797 .56
Microbiologic status 1.044 0.915-1.173 .51
Emergence of new skin islets 1.731 0.996-2.466 .06
Reduction in calf
circumference
1.524 0.995-2.053 .07
OR, Odds ratio; CI, confidence interval.venous leg ulcerations are healing ulcers, reducing pain and
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of the calf muscle is achieved with compression hosiery or
compression bandages. Two types of compression ban-
dages are used for the treatment of venous leg ulcers: elastic
and inelastic bandages. Inelastic bandages provide high
pressure with muscle contraction (high working pressures)
but limited pressure at rest. Conversely, elastic compression
bandages provide sustained pressures and conform to the
leg better.8 Different bandaging systems have been devel-
oped for the treatment of venous leg ulcers (single-layer or
multilayer bandaging systems). A well-known systematic
review of compression treatment published in 1997 found
that multilayer compression bandages were superior com-
pared with single-layer bandage systems.9 Multilayer ban-
daging systems were more effective compared with single-
layer compression in four trials in the Cochrane Database
Systemic Review published in 2001.10 This review identi-
fied 22 trials reporting 24 comparisons. In five trials, elastic
compression was more effective than nonelastic compres-
sion, whereas no difference in healing rates between four-
layer and other high-compression multilayered systems was
identified (three trials). Compression stockings were eval-
uated only in two trials. In first trial, a combination of a
high-compression stocking and thromboembolism stock-
ing was more effective than a short-stretch bandage. The
second trial reported no difference between the compres-
sion stockings and Unna boots.
Published healing rates of venous ulcers obtained with
compression therapy vary widely from 40% to 90%.11-20 Fur-
ther trials are necessary to identify the best treatment options,
especially for nonhealing ulcers. A possible way to predict
nonhealing venous leg ulcers is to examine the prognostic risk
factors that are consistently found in a number of published
studies (large wound area and wound of long duration).
Wounds with either or both of these factors are at risk for not
healing.9 The results of our study do not support these find-
ings. Large and long-lasting ulcers could be healed, although
more time is needed. Most ulcers difficult to treat with com-
pression therapy showing a nonhealing tendency in our study
were the ulcers with the deepest presentation (2 cm deep).
Also, lateral ulcers were more difficult to treat, probably be-
cause it is difficult to achieve adequate compression. A de-
crease in wound size during the first 50 days of treatment is a
favorable prognostic factor for healing. According to some
studies, approximately 50% to 70% of venous ulcers with a
decrease in wound size during the first month of compression
therapywill be healed after 6months of the treatment.9 In our
study, only five patients in the treatment group did not heal at
the 500-day treatment mark. In three patients, the ulcer
surface was considerably smaller (50%) compared with the
beginning of the treatment, and in one patient the ulcer was
smaller (30%). Only in one patient was no improvement seen.
A wound swabbing in this patient showed the presence of
-hemolytic streptococcus group A, which may be the cause
for nonhealing. In obese patients, more time is needed for
ulcer closure. We think that the main reason for this is immo-
bility and, therefore, inactivity of their muscle pump.The good results achieved in our study in the treatment
group could be to some extent due to the tubular form of
the Tubulcus. A tubular form gives, in our opinion, the best
support to the calf muscle and mimics muscle fascia. How-
ever, the Tubulcus by itself can not provide sufficient
pressure to the calf muscle for the treatment of extensive
ulcers. Sufficient pressure of 50 to 55 mmHg was provided
with an additional layer of elastic bandage. Further trials are
needed to clarify the potential treatment benefits of this
treatment combination (a tubular compression device plus
an elastic bandage).
Disciplined high-pressure bandaging has the potential
to heal large ulcers to a high degree. It is possible with
high-pressure compression to decrease the recurrence rate
during the first year after healing, but the long-term recur-
rence rate is not known.
CONCLUSION
This study suggests that for extensive venous ulcer-
ation, multilayer compression therapy with the Tubulcus
provides a high healing rate. Sustained compression of 35
mmHg is necessary after ulcer healing to avoid recurrence.
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